AIM: A consensus treatment strategy for recurrent @entity1544 ( @entity1544 ) has not been established. The purpose of the present study was to analyse the mode of recurrence, and evaluate the role of surgical salvage treatment in recurrence of @entity1544 . METHODS: Recurrence was detected in 131 of 367 consecutive @entity1 with @entity1544 . We retrospectively analysed the mode of recurrence and treatment for recurrence. Recurrence was divided into four types; lymph node, hematogeneous, mixed and local. Treatments were classified into four groups; chemotherapy alone (C group), radiation therapy +/- chemotherapy (R group), surgery +/- other therapy (S group), and no therapy (N group). RESULTS: Of the 131 recurrences, the number of @entity1 with lymph node, hematogeneous, mixed and local recurrence was 43, 44, 40 and 4, respectively. The number of @entity1 in the C, R, S, N groups was 35, 35, 24 and 37, respectively. Of the 24 @entity1 who received surgical treatment for recurrence, the number of @entity1 with lymph node, hematogeneous, mixed and local recurrence was 11, 6, 6 and 1, respectively. The number of lesions in hematogeneous recurrence was 2 or less. The survival rate from recurrence to @entity204 in the C, R, S and N groups was 0, 3.9, 6.7 and 0%, respectively. A statistically significant difference was found in these groups (p < 0.0001). CONCLUSIONS: Salvage surgery is one of the useful treatment tools for resectable metastatic lesions. In such cases, the number of lesions, recurrent sites and effectiveness of chemotherapy and/or radiotherapy should be carefully evaluated.

The role of salvage surgery for recurrence of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1544 :: ('MESH:D018307', 'Disease') :: ['esophageal squamous cell cancer', 'ESCC'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity1544 :: (MESH:D018307,Disease) :: ['esophageal squamous cell cancer']
